A carregar...
P04.07 Relapse in a paucisymptomatic form of multiple sclerosis in a patient treated with nivolumab
INTRODUCTION: The successful clinical application of immune checkpoint-blockade therapies, as anti-CTLA4, anti-PDL1 and antiPDL2 antibodies, is changing the way to treat patients with cancer. Nivolumab is an anti-PD-1 antibody with promising efficacy in a broad of neoplasias. During treatment with t...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782583/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.085 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|